Malaria News and Research

Latest Malaria News and Research

Report outlines strong scientific foundations for taking actions to stop the next pandemic

As the world struggles to contain COVID-19, a group of leading, scientific experts from the U.S., Latin America, Africa, and South Asia released a report today outlining the strong scientific foundations for taking actions to stop the next pandemic by preventing the spillover of pathogens from animals to people.

18 Aug 2021

Small NIH clinical trial shows that new monoclonal antibody can prevent malaria

One dose of a new monoclonal antibody discovered and developed at the National Institutes of Health safely prevented malaria for up to nine months in people who were exposed to the malaria parasite.

11 Aug 2021

Microbe transmitted between mosquitoes could be key to controlling malaria

A microbe that is transmitted between male and female mosquitoes but can also block reproduction could be key to controlling malaria by targeting its release into mosquito populations, a study says.

10 Aug 2021

Study demonstrates the potency of herbal medicines against Bartonella henselae

Bay Area Lyme Foundation, a leading sponsor of Lyme disease research in the U.S., today announced the publication of new data showing that herbal medicines have potent activity in test tubes compared to pharmaceuticals commonly-prescribed for the treatment of Bartonella henselae, a bacterium believed to be carried by ticks and the cause of cat scratch fever.

5 Aug 2021

Invasive 'famine weed' could escalate the spread of malaria

An invasive weed could escalate the spread of malaria in East Africa after scientists found new evidence that it creates a favourable breeding ground for female mosquitoes, which transmit malaria.

5 Aug 2021

New LSHTM spin-out company aims to improve detection and control of infectious diseases

Two spin-out companies from the London School of Hygiene & Tropical Medicine (LSHTM) have merged to form a new company that will improve the detection and control of infectious diseases.

4 Aug 2021

Open-access database could speed up repurposing of old drugs as new treatments

Researchers have created a new open-access database of information on drug candidates and how they are metabolized by the body, which could help speed up the repurposing of old drugs as new treatments.

3 Aug 2021

Study looks at potent phytocompounds from Himalayan herbs to treat COVID-19

Considering the antiviral activity of medicinal herbs, a new study published in the journal Current Pharmacology Reports focuses on the identification of potent phytochemicals from Himalayan herbs, namely, Rheum emodi, Thymus serpyllum, and Artemisia annua, for the treatment of COVID-19.

1 Aug 2021

China earns a malaria-free certification from WHO

Following a 70-year effort, China has been awarded a malaria-free certification from WHO – a notable feat for a country that reported 30 million cases of the disease annually in the 1940s.

28 Jul 2021

Moderate drinking may be linked with decreased risk of heart attack and death in adults with CVD

Drinking up to 105 grams of alcohol per week - equivalent to 13 UK units of alcohol, less than six pints of medium-strength beer or just over a bottle of wine - may be associated with a decreased risk of heart attack, stroke, angina or death among those with cardiovascular disease (CVD).

27 Jul 2021

Research uncovers an unexpected role for immune T cells in protection against malaria

Advanced technologies have been used to solve a long-standing mystery about why some people develop serious illness when they are infected with the malaria parasite, while others carry the infection asymptomatically.

23 Jul 2021

Scientists seek to block pathogen’s most reliable weapon to cause severe malaria

The parasites that cause severe malaria are well-known for the sinister ways they infect humans, but new research may lead to drugs that could block one of their most reliable weapons: interference with the immune response.

21 Jul 2021

Study proves effectiveness of Artemisia annua against SARS-CoV-2 in vitro

A multinational research group has been the first to show the excellent activity of artemisinin-based treatment against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in human cell lines – including a specific type of lung cells. Their findings were recently published in the journal Scientific Reports.

19 Jul 2021

Oral prodrug delivers carbon monoxide to protect against acute kidney injury

An oral prodrug developed by a team of scientists led by Binghe Wang, Regents' Professor of Chemistry at Georgia State University, delivers carbon monoxide to protect against acute kidney injury, according to a new paper published in Chemical Science.

19 Jul 2021

Malaria News and Research

Latest Malaria News and Research

Report outlines strong scientific foundations for taking actions to stop the next pandemic

Small NIH clinical trial shows that new monoclonal antibody can prevent malaria

Microbe transmitted between mosquitoes could be key to controlling malaria

Study demonstrates the potency of herbal medicines against Bartonella henselae

Invasive 'famine weed' could escalate the spread of malaria

New LSHTM spin-out company aims to improve detection and control of infectious diseases

Open-access database could speed up repurposing of old drugs as new treatments

Study looks at potent phytocompounds from Himalayan herbs to treat COVID-19

China earns a malaria-free certification from WHO

Moderate drinking may be linked with decreased risk of heart attack and death in adults with CVD

Research uncovers an unexpected role for immune T cells in protection against malaria

Scientists seek to block pathogen’s most reliable weapon to cause severe malaria

Study proves effectiveness of Artemisia annua against SARS-CoV-2 in vitro

Oral prodrug delivers carbon monoxide to protect against acute kidney injury

Discovery of SARS-CoV-2–induced pathways uncovers groundbreaking drug repurposing strategies

Simple blood tests may help prevent inaccuracy in the diagnosis of severe malaria

Two chemoattenuated PfSPZ malaria vaccines provide strong and lasting protection

Inadequate exposure to UVB light may be linked with increased risk of colorectal cancer

New malaria vaccine is undergoing Phase 1 trials but current results show it provides strong and long-lasting protection

Researchers identify proteins that contribute to the pathogenicity of COVID-19 virus

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Malaria News and Research

Latest Malaria News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in